Previous 10 | Next 10 |
2024-02-27 14:55:45 ET Denver, CO, February 27, 2024, ( 247marketnews.com ) ( NASDAQ: HOLO ) ( NASDAQ:SPRC ) ( NASDAQ:INBS ) ( NASDAQ:SYTA ) Should remain on your watchlists in the coming days. The trend of volatile low float stocks continues to create significant up...
New patent applications build upon Clearmind’s broad IP protection in the psychedelic space Vancouver, Canada, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY0) (“Clearmind” or the “company”), a biotech company focu...
TEL AVIV, Israel, Feb. 27, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part o...
2024-02-20 12:50:54 ET Gainers: Pop Culture Group Co Ltd ( CPOP ) +176% . AgriFORCE Growing Systems ltd ( AGRI ) +95% . Trxade Health ( MEDS ) +92% . Intuitive Machines ( LUNR ) +48% . Iovance Biotherapeutics ( IOVA ) +39% . ...
2024-02-20 10:51:37 ET More on SciSparc Ltd. SciSparc announces $20M standby equity purchase agreement SciSparc stock jumps 25% amid MitoCare X Bio investment Financial information for SciSparc Ltd. Read the full article on Seeking Alpha For further d...
2024-02-20 10:00:11 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Healthcare dealmakers see inc...
2024-02-20 09:32:32 ET DENVER, Colo., Feb 20, 2024 (www.247marketnews.com)- Clearmind Medicine Inc. (NASDAQ: CMND ) jointly announced, this morning, with SciSparc Ltd. (NASDAQ: SPRC ), that Clearmind filed three patent applications, under the international Patent Cooperation Treaty,...
Vancouver, Canada, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems,...
TEL AVIV, Israel, Feb. 20, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part o...
2024-02-12 12:13:32 ET More on ATAI, COMPASS Pathways, etc. Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play Mind Medicine: Positive MM-120 Data Leads To Other 2024 Catalysts De-Risking Psychedelics: Compass Pathways, Cybin And Atai ...
News, Short Squeeze, Breakout and More Instantly...
SciSparc Ltd. Company Name:
SPRC Stock Symbol:
NASDAQ Market:
PRA Group Inc. (PRAA) is expected to report $-0.15 for Q1 2024 Bowman Consulting Group Ltd. (BWMN) is expected to report $-0.04 for Q1 2024 Noble Corporation plc A (NE) is expected to report $0.56 for Q1 2024 Velo3D Inc. (VLD) is expected to report for Q3 2024 Axon Enterprise Inc....
SciSparc Ltd. (SPRC) is expected to report for quarter end 2023-12-31
Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial res...